Coya Therapeutics, Inc. has Treg therapies for neurodegenerative and autoimmune diseases, targeting ALS, FTD, AD, and PD. However, their lead candidate is now clearly COYA 302. This drug basically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback